WEBSITE BSE:511108 NSE: SHIVATEX Inc. Year: 1980 Industry: Textile - Spinning
Last updated: 15:43
Shiva Texyarn Ltd manufactures and markets cotton yarn, and technical and different value-added fabric merchandise in India and the world over. The organization gives combed, carded, and compact yarns; slub and fancy yarns; quick dry merchandise; quick healthy products, consisting of mattresses protectors; and baby merchandise below the Q-Club logo. It also offers door, window, and bathe curtains, in addition to cushion covers; knitwear, light weight shells, seam sealed, multi layered, fleece and pile fabric, and breathable movie laminated garm...Read More
Shiva Texyarn Ltd manufactures and markets cotton yarn, and technical and different value-added fabric merchandise in India and the world over. The organization gives combed, carded, and compact yarns; slub and fancy yarns; quick dry merchandise; quick healthy products, consisting of mattresses protectors; and baby merchandise below the Q-Club logo. It also offers door, window, and bathe curtains, in addition to cushion covers; knitwear, light weight shells, seam sealed, multi layered, fleece and pile fabric, and breathable movie laminated garments; and extreme cold weather garb, super high altitude mountaineering clothing, intense cold climate combat glove structures, and inner and external frame rucksacks. In addition, the corporation gives bedding range, together with sheets, cover covets, and fleece blankets; kitchen articles comprising aprons, pot holders, and table cloths; tub, wipe, and swimming towels; acrylic coated, PU coating products, and artwork canvas and virtual canvas merchandise; and luggage, together with sports and school baggage, and women and professional luggage for camping and photography beneath the WULF call. The agency was incorporated in 1980 and is primarily based in Coimbatore, India. As of February 21, 2022, Shiva Texyarn Ltd operates as a subsidiary of Vedanayagam Hospital (p) Ltd. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹214 Cr.
Stock P/E 17.7
P/B 1.5
Current Price ₹164.8
Book Value ₹ 110.4
Face Value 10
52W High ₹260.2
Dividend Yield 0.36%
52W Low ₹ 157.2
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 90 | 99 | 76 | 70 | 61 | 95 | 75 | 92 | 76 | 105 |
| Other Income | 1 | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 0 | 1 |
| Total Income | 91 | 99 | 76 | 74 | 61 | 96 | 75 | 93 | 77 | 106 |
| Total Expenditure | 90 | 93 | 74 | 71 | 53 | 85 | 68 | 83 | 67 | 92 |
| Operating Profit | 0 | 6 | 3 | 3 | 8 | 10 | 7 | 10 | 9 | 14 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -6 | -0 | -4 | -3 | 2 | 4 | 1 | 3 | 3 | 7 |
| Provision for Tax | -0 | 2 | 3 | -8 | 1 | 1 | -0 | -3 | 0 | 1 |
| Profit After Tax | -6 | -3 | -7 | 5 | 1 | 3 | 2 | 6 | 2 | 6 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -6 | -3 | -7 | 5 | 1 | 3 | 2 | 6 | 2 | 6 |
| Adjusted Earnings Per Share | -4.6 | -2 | -5.7 | 4 | 1 | 2.1 | 1.4 | 4.8 | 1.9 | 4.5 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 450 | 559 | 335 | 323 | 348 |
| Other Income | 1 | 2 | 5 | 2 | 2 |
| Total Income | 451 | 561 | 340 | 325 | 351 |
| Total Expenditure | 396 | 490 | 328 | 289 | 310 |
| Operating Profit | 55 | 72 | 12 | 36 | 40 |
| Interest | 23 | 27 | 11 | 12 | 13 |
| Depreciation | 17 | 18 | 15 | 14 | 16 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 15 | 27 | -14 | 10 | 14 |
| Provision for Tax | 4 | 12 | -3 | -2 | -2 |
| Profit After Tax | 10 | 15 | -11 | 12 | 16 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 10 | 15 | -11 | 12 | 16 |
| Adjusted Earnings Per Share | 4.7 | 7 | -8.3 | 9.3 | 12.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | -10% | 0% | 0% |
| Operating Profit CAGR | 200% | -13% | 0% | 0% |
| PAT CAGR | 0% | 6% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -24% | 7% | 5% | 2% |
| ROE Average | 9% | 4% | 4% | 4% |
| ROCE Average | 10% | 7% | 8% | 8% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 159 | 174 | 123 | 136 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 87 | 65 | 30 | 27 |
| Other Non-Current Liabilities | 44 | 46 | 33 | 27 |
| Total Current Liabilities | 191 | 232 | 103 | 114 |
| Total Liabilities | 481 | 517 | 289 | 304 |
| Fixed Assets | 289 | 295 | 181 | 168 |
| Other Non-Current Assets | 37 | 31 | 9 | 13 |
| Total Current Assets | 154 | 191 | 99 | 123 |
| Total Assets | 481 | 517 | 289 | 304 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 7 | 8 | 6 | 1 |
| Cash Flow from Operating Activities | 27 | 57 | 2 | 13 |
| Cash Flow from Investing Activities | -12 | -15 | 5 | -3 |
| Cash Flow from Financing Activities | -14 | -39 | -12 | -10 |
| Net Cash Inflow / Outflow | 1 | 3 | -5 | -0 |
| Closing Cash & Cash Equivalent | 8 | 11 | 1 | 1 |
| # | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.68 | 6.97 | -8.31 | 9.31 |
| CEPS(Rs) | 12.61 | 15.16 | 3.14 | 20.38 |
| DPS(Rs) | 1.1 | 1.6 | 0 | 0.6 |
| Book NAV/Share(Rs) | 73.55 | 80.54 | 95.03 | 104.66 |
| Core EBITDA Margin(%) | 12.06 | 12.36 | 2.23 | 10.43 |
| EBIT Margin(%) | 8.45 | 9.64 | -0.71 | 6.65 |
| Pre Tax Margin(%) | 3.23 | 4.83 | -4.09 | 3 |
| PAT Margin (%) | 2.25 | 2.69 | -3.19 | 3.72 |
| Cash Profit Margin (%) | 6.05 | 5.86 | 1.2 | 8.14 |
| ROA(%) | 2.1 | 3.02 | -2.67 | 4.07 |
| ROE(%) | 6.37 | 9.05 | -7.25 | 9.32 |
| ROCE(%) | 9.43 | 13.29 | -0.77 | 9.51 |
| Receivable days | 31.8 | 31.39 | 48.3 | 40.99 |
| Inventory Days | 74.38 | 66.19 | 90.25 | 73 |
| Payable days | 30.21 | 36.71 | 60.16 | 48.74 |
| PER(x) | 22.13 | 52.35 | 0 | 18.66 |
| Price/Book(x) | 1.41 | 4.53 | 1.51 | 1.66 |
| Dividend Yield(%) | 1.06 | 0.44 | 0 | 0.35 |
| EV/Net Sales(x) | 1.02 | 1.81 | 0.83 | 1 |
| EV/Core EBITDA(x) | 8.35 | 14.12 | 22.49 | 8.95 |
| Net Sales Growth(%) | 0 | 24.19 | -39.99 | -3.75 |
| EBIT Growth(%) | 0 | 41.72 | -104.47 | 995.82 |
| PAT Growth(%) | 0 | 48.92 | -171.47 | 212.04 |
| EPS Growth(%) | 0 | 48.92 | -219.12 | 212.04 |
| Debt/Equity(x) | 1.54 | 1.34 | 0.78 | 0.73 |
| Current Ratio(x) | 0.81 | 0.82 | 0.96 | 1.07 |
| Quick Ratio(x) | 0.33 | 0.35 | 0.42 | 0.43 |
| Interest Cover(x) | 1.62 | 2 | -0.21 | 1.82 |
| Total Debt/Mcap(x) | 1.09 | 0.3 | 0.51 | 0.44 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 |
| FII | 0.03 | 0 | 0 | 0.23 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 25.93 | 25.95 | 25.95 | 25.72 | 25.96 | 25.96 | 25.96 | 25.95 | 25.96 | 25.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.34 | 0.34 | 0.34 | 0.33 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
